Allurion, while battling declining revenues, is targeting the loss in muscle mass seen in patients on GLP-1RA therapy.

Allurion Technologies shares soared 200% Friday as it planned to test its gastric balloon with the key ingredient in popular weight-loss drugs to see if the combination improves patients' muscle mass.

Anduril, the closely held technology startup that makes autonomous systems and weapons for the military, on Thursday announced plans to build a $1 billion factory in Columbus, Ohio. The company ...

Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient ...

Our 2025 plan includes scaling our new commercial strategy, advancing the Allurion Balloon through the FDA approval process, setting the company up for a profitable 2026, expanding our digital ...

Allurion Technologies shares rose after agreeing to a private placement with expected gross proceeds of $2.5 million that will extend its runway through early 2026. The stock was up 13% to $3.37 ...

and product designers who have spent hours working out in gyms and fitness classes — these are the best all-around men’s workout shoes. I’ve noted where each of these shoes excels most ...

To find some outstanding pairs that fit all of these specs, my colleague Arielle Avila and I polled many stylish men — including designers, photographers, and our own writers — and dug through ...

Our 2025 plan includes scaling our new commercial strategy, advancing the Allurion Balloon through the FDA approval process, setting the company up for a profitable 2026, expanding our digital ...